Workforce Optimization Through Voluntary Early Retirement
First written in FY2021-Q2. 2 of 6 entries say "Advanced", first in FY2021-Q3. Latest entry: FY2026.
7 other companies' latest entry also says "Other".
- FY2026Increase in structural improvement expenses for logistics operationsAnnual report
「Amortization of goodwill of ¥9,543 million and business structure improvement expenses of ¥4,554 million related to logistics operations and other activities in the wholesale business for prescription pharmaceuticals and other products were recorded as extraordinary losses.」
Structural improvement expenses for logistics operations and other activities increased from ¥4,291 million in the first half of the previous fiscal year to ¥4,554 million for the full fiscal year. The company explained that the expenses arose from transfers of logistics personnel and other measures among group companies. - FY2026-H1Recognition of structural improvement expenses for logistics operationsAnnual report
「The company recorded ¥4,291 million in structural improvement expenses related to logistics operations in its wholesale business for prescription pharmaceuticals and other products as an extraordinary loss. As a result, extraordinary gains and losses totaled ¥5,539 million, an ¥846 million improvement from the same period of the previous year.」
In connection with its structural reform and workforce optimization initiatives, the company recorded ¥4,291 million in structural improvement expenses related to logistics operations in its wholesale business for prescription pharmaceuticals and other products. The expense recognition is confirmed, but no specific details or completion of the improvements are provided. - FY2023-Q3AdvancedAnnual report
「Amid difficult conditions, including surging electricity and fuel costs such as gasoline, the company worked to improve productivity by optimizing its workforce through measures including consolidating deliveries and moving order cut-off times earlier, as part of structural reforms aimed at sustainable growth.」
In addition to soliciting voluntary retirements, the company implemented specific operational measures for structural reform and workforce optimization, including consolidating deliveries and moving order cut-off times earlier. - FY2021RestatedAnnual report
「As part of structural reforms aimed at sustainable growth, the company solicited applications for voluntary retirement from employees of its consolidated wholly owned subsidiaries 株式会社メディセオ (Chuo-ku, Tokyo), 株式会社エバルス (Minami-ku, Hiroshima) and 株式会社アトル (Higashi-ku, Fukuoka), with the end of February 2021 set as the retirement date. The number of applicants was 560, and the company is working to optimize its workforce.」
Voluntary retirement was implemented at 3 subsidiaries, with 560 applicants, and the company continues its workforce optimization efforts. - FY2021-Q3AdvancedAnnual report
「As part of structural reforms aimed at sustainable growth, the company solicited applications for voluntary retirement from employees of its consolidated wholly owned subsidiaries 株式会社メディセオ (Chuo-ku, Tokyo), 株式会社エバルス (Minami-ku, Hiroshima) and 株式会社アトル (Higashi-ku, Fukuoka), with 28 February 2021 set as the retirement date. The number of applicants was 560, and the company is working to optimize its workforce.」
The company solicited voluntary retirements at 3 subsidiaries, receiving 560 applications. Workforce optimization progressed from the resolution and planning stage to implementation, with applicants preparing to retire on 28 February 2021. - FY2021-Q2First statedAnnual report
「At a meeting of the Board of Directors held on 30 October 2020, the company resolved to solicit applications for voluntary retirement at its consolidated wholly owned subsidiaries 株式会社メディセオ, 株式会社エバルス and 株式会社アトル. The group will solicit applications for voluntary retirement to optimize its workforce as part of structural reforms aimed at sustainable growth. Eligible employees: employees aged 45 or older with at least 10 years of service. Application period: 14 December 2020 to 25 December 2020. Retirement date: 28 February 2021.」
As part of structural reforms and workforce optimization aimed at sustainable growth, the company resolved to solicit voluntary retirements at メディセオ, エバルス and アトル. It specified the eligibility requirements, application period and retirement date.